Cancer Support Group

Saturday, Jan 16th

Last update:06:42:40 AM GMT

Home News and Update Year 2010 Breast Cancer: Lymph Node op Not a Must

Breast Cancer: Lymph Node op Not a Must

Times of India
10 February 2011
Chicago, India

Women with early breast cancer may not need to have surgery to remove cancerous lymph nodes under the armpit, US researchers said on Tuesday.

The finding may spare many women the pain and years of side effects related to this long–standing procedure. Certain women with breast cancer who had only their sentinel lymph node removed – the lymph node closest to the cancer – survived just as long as women who had more extensive surgery to remove lymph nodes in the armpit, known as axillary lymph node dissection or ALND, the researchers found.

For the study, published on Tuesday in the Journal of the American Medical Association, Armando Giuliano of Saint John's Health Center in Santa Monica, California, and colleagues analyzed the two procedures in women with invasive breast cancer who had their tumors removed and underwent radiation and chemotherapy.

Overall survival rates after five years were about the same in both groups. Removing cancerous lymph nodes in these women may not be necessary because the radiation and chemotherapy attacks cancers in the lymph nodes before they have time to spread, the team said.

They noted that removing lymph nodes from the armpit "carries an indisputable and often unacceptable risk of complications," including infection and chronic and painful swelling of the arm. The findings, when combined with other research, are strong enough to change the way certain women with breast cancer are treated. "Implementation of this practice change would improve clinical outcomes in thousands of women each year by reducing the complications associated with ALND and improving quality of life with no diminution in survival," the team wrote.

Breast cancer is the second–leading cause of cancer death among US women, after lung cancer. It kills 500,000 people globally each year and is diagnosed in close to 1.3 million people around the world.

Test to spell end to prostate surgery
Coming soon: A simple test which could save thousands of prostate cancer patients from surgery, say scientists. A new research has shown that men with certain genes are three times more likely to have the most dangerous form. While these patients need surgery, those without these genes are less likely to see their tumours grow quickly and may be able to avoid surgery altogether. Early results from a trial by a British team suggest that the tests could be available in a few years and transform the outlook for thousands of men with prostate cancer – the most common form of male cancer, the Daily Express reported.

Disclaimer: The news story on this page is the copyright of the cited publication. This has been reproduced here for visitors to review, comment on and discuss. This is in keeping with the principle of ‘Fair dealing’ or ‘Fair use’. Visitors may click on the publication name, in the news story, to visit the original article as it appears on the publication’s website.


This is YOUR sites, so if you have suggestions or feedback on how we can improve it for you, please let us know! We do our best to keep up!

Make a Suggestion
Manthan Award

Link to Aarogya

aarogya logo